PhoreMost and NeoPhore Receive Innovate UK Funding to Support Development of a Novel Small-Molecule Cancer Immunotherapy Programme

CAMBRIDGE, England, April 27, 2018 /PRNewswire/ -- Grant award funds expanded operations and recognizes innovative drug discovery programme PhoreMost Limited and NeoPhore Limited today announced the companies will receive £1.0 million of funding following award of a Biomedical...

from PR Newswire: //https://ift.tt/2Jxe52W